John C. Jorgenson
PEOPLE

John C. Jorgenson

Associate
jorgenson.john@dorsey.com

Overview

John focuses on mergers and acquisitions, joint ventures, corporate governance, securities law, and general corporate law.

John advises public and private companies, as well as private equity sponsors, on U.S. and cross-border corporate transactions, including acquisitions, divestitures, carveouts, auctions, joint ventures, and reorganizations as well as corporate governance matters. He has advised on M&A transactions across a variety of industries, including biomedical, defense, finance, food, beverage, and agribusiness, healthcare, manufacturing, media, gaming and entertainment, pharmaceuticals, real estate, retail, and technology. John has completed business combination transactions alongside local counsel in over a dozen countries, including the U.S., Canada, the U.K., Scandinavia, and continental Europe.

Prior to joining Dorsey & Whitney LLP, John practiced for several years in the Mergers and Acquisitions group at Skadden, Arps, Slate, Meagher & Flom LLP in New York.

Education & Admissions

University of Iowa College of Law (Juris Doctor, 2017),

  • High Distinction
  • Order of the Coif
  • Award for Outstanding Scholastic Achievement
  • Randy J. Holland Award for Corporate Scholarship
  • Iowa Law Review, Contributing Editor

Johns Hopkins University (Master of Arts in History, 2009), Four-year BA/MA program scholar

Johns Hopkins University (Bachelor of Arts in History and German, 2009),

  • University Honors
  • History Departmental Honors

Admissions

  • Minnesota
  • New York

Experience

Representative Experience

  • A philanthropic software technology company in its acquisition by a U.S. private equity firm.
  • A privately held company in its acquisition of 15 retail locations consisting of grocery, convenience, and hardware stores.
  • A privately held health care company in its $2.1 billion all-stock acquisition by a U.S. public company.
  • A portfolio company of private equity firm in its acquisition of the commercial health insurance payer-focused products business from a U.S. public company.
  • A pet food manufacturing company in the sale of its private label pet food business.
  • A food and beverage company in its worldwide corporate reorganization.
  • A publicly traded specialty pharmaceutical company in its acquisition by a Canadian public company.
  • A portfolio company of private equity firm in its acquisition of a U.K. privately held defense company and its subsidiaries.
  • A special purpose acquisition company in its $1 billion merger with a consumer products company.
  • A private equity firm in the sale of an infrastructure-focused portfolio company to another private equity firm.
John C. Jorgenson